EP
GOSS icon

Eversept Partners’s Gossamer Bio GOSS Stock Holding History

Eversept Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-925,233
Closed -$2.43M – 110
2025
Q3 		$2.43M Sell
925,233
-770,529
-45% -$1.7M 0.17% 63
2025
Q2 		$2.09M Sell
1,695,762
-2,201,079
-56% -$2.4M 0.19% 52
2025
Q1 		$4.29M Sell
3,896,841
-1,081,617
-22% -$1.25M 0.44% 35
2024
Q4 		$4.5M Hold
4,978,458
– – 0.4% 44
2024
Q3 		$4.91M Sell
4,978,458
-505,690
-9% -$486K 0.34% 39
2024
Q2 		$4.94M Sell
5,484,148
-510,324
-9% -$382K 0.34% 43
2024
Q1 		$7.07M Sell
5,994,472
-438,243
-7% -$482K 0.47% 41
2023
Q4 		$5.87M Buy
6,432,715
+2,004,858
+45% +$1.48M 0.52% 35
2023
Q3 		$3.69M Buy
4,427,857
+3,678,160
+491% +$4.24M 0.31% 51
2023
Q2 		$900K Sell
749,697
-602,368
-45% -$750K 0.08% 64
2023
Q1 		$1.7M Buy
1,352,065
+1,197,853
+777% +$2.29M 0.12% 53
2022
Q4 		$335K Sell
154,212
-394,219
-72% -$3.25M 0.03% 62
2022
Q3 		$6.57M Buy
548,431
+80,128
+17% +$995K 0.57% 35
2022
Q2 		$3.92M Buy
468,303
+93,580
+25% +$725K 0.28% 51
2022
Q1 		$3.25M Buy
374,723
+334,813
+839% +$3.23M 0.25% 53
2021
Q4 		$451K Sell
39,910
-110,000
-73% -$1.31M 0.03% 100
2021
Q3 		$1.88M Buy
+149,910
New +$1.38M 0.13% 79

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Eversept Partners's GOSS Position: Q4 2025 in Review

Eversept Partners sold out of Gossamer Bio (GOSS) in Q4 2025, closing a stake of 925,233 shares — an estimated $2.43M sold.

Eversept Partners first reported a position in GOSS in Q3 2021 and held it in 17 quarters. The position peaked at $7.07M in Q1 2024. 195 funds tracked by Wall St. Rank hold GOSS as of Q4 2025.

  • Eversept Partners reported no remaining Gossamer Bio position as of Q4 2025 after selling out during the quarter.
  • Eversept Partners sold 925,233 Gossamer Bio shares in Q4 2025, an estimated $2.43M.
  • Eversept Partners first reported a position in Gossamer Bio in Q3 2021 and held it in 17 quarters.
  • Eversept Partners's Gossamer Bio position peaked at $7.07M in Q1 2024.
  • 195 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2025.

Based on Eversept Partners's 13F filing for Q4 2025, filed 17 Feb 2026.